11
views
0
recommends
+1 Recommend
1 collections
    0
    shares

      Call for Papers: Artificial Intelligence in Gastroenterology

      Submit here before May 31, 2024

      About Digestion: 3.2 Impact Factor I 6.4 CiteScore I 0.914 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found

      Inflammatory Bowel Disease in Indian Migrants in Fiji

      research-article
      , ,
      Digestion
      S. Karger AG
      Inflammatory bowel disease, Crohn’s disease, Ulcerative colitis

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          A pilot study to estimate the incidence of inflammatory bowel disease in Fiji is reported. Data from 1985 and 1986 for Indian migrants, Melanesians and other groups show the incidence of ulcerative colitis was 1.7/10<sup>5</sup>/year, in Indians, 0.15/10<sup>5</sup>/year in Melanesians and 1.4/10<sup>5</sup>/year in others. The minimum incidence of Crohn’s disease is 0.14/10<sup>5</sup>/year. Indians are at significantly greater risk than Melanesians of developing ulcerative colitis.

          Related collections

          Author and article information

          Journal
          DIG
          Digestion
          10.1159/issn.0012-2823
          Digestion
          S. Karger AG
          0012-2823
          1421-9867
          1991
          1991
          04 February 2009
          : 50
          : 2
          : 82-84
          Affiliations
          Leicester General Hospital, Leicester, UK
          Article
          200743 Digestion 1991;50:82–84
          10.1159/000200743
          1804736
          7e4653cb-6fdb-4db9-b4cb-1d9a63edcb88
          © 1991 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          : 24 June 1991
          Page count
          Pages: 3
          Categories
          Original Paper

          Oncology & Radiotherapy,Gastroenterology & Hepatology,Surgery,Nutrition & Dietetics,Internal medicine
          Inflammatory bowel disease,Ulcerative colitis,Crohn’s disease

          Comments

          Comment on this article